Assessment of diagnostic value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as inflammatory indicators and indirect endothelial dysfunction markers in patients with acute pulmonary embolism
More details
Hide details
Human Anatomy Research Group, Department of Human Anatomy, Medical University of Lublin
Department of Human Anatomy, Medical University of Lublin
Department of Orthopedics and Traumatology, Medical University of Lublin
1st Department of Radiology, Medical University of Lublin
Department of Neurosurgery and Pediatric Neurosurgery, Medical University of Lublin
Department of Pharmacology and Pharmacodynamics, Medical University of Lublin.
Piotr Piech   

Department of Human Anatomy, Medical University of Lublin, ul. Jaczewskiego 4, 20-090 Lublin, Poland
J Pre Clin Clin Res. 2018;12(1):26–29
Introduction. Acute pulmonary embolism (APE) is a serious cardiovascular disease associated with high mortality rates despite advanced therapeutic options and widely used antithrombotic prophylaxis. The variety of nonspecific symptoms and comorbidities result in APE not being properly diagnosed in many patients. Therefore, identifying new, easily accessible and cheap diagnostic markers for the disease is important. Studies conducted for the last decade have undoubtedly confirmed the role of inflammation and endothelial damage in pathogenesis of APE, and the elevated NLR and PLR values have been considered as a new markers of inflammation.

Material and methods:
Computed tomography pulmonary angiography (CTPA) and routine blood tests were performed in all the patients, after which neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were calculated, based on neutrophil, platelet and lymphocyte counts. Finally, statistical analysis of the results in groups with confirmed and ruled-out APE was performed.

There were no statistically significant differences in the values of NLR and PLR between patients with confirmed and ruled-out APE. Chi-square and Mann-Whitney tests were used with p≤0.05 considered significant.

According to the results of this study, it was not possible to demonstrate the usefulness of NLR and PLR in the diagnostics of APE. To the best of the authors’ knowledge, this is the first study in the literature considering the role of NLR and PLR in the diagnostics of APE.

Konstantinides SV, Torbicki A, Agnelli G, et al. ESC Committee for Practice Guidelines (CPG). Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). EurHeart J 2014; 35: 3033–69.
Strzelecki Z, Szymborski J, et al. Zachorowalność i umieralność na choroby układu krążenia a sytuacja demograficzna Polski. Warsaw: Rządowa Rada Ludnościowa. 2015.
Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, et al. (VTE) in Europe. The number of VTE events and associated morbidity and mortality. ThrombHaemost. 2007; 98: 756–64.
Życińska K, Wiktorowicz M, Tomasik D, et al. Clinical presentation of pulmonary embolism in general practice. Family Medicine & Primary Care Review 2013; 15(3): 430–433.
Fox EA, Kahn SR. The relationship between inflammation and venous thrombosis. A systemic review of clinical studies. ThromHaemost 2005; 94: 362–5.
Zee RY, Glynn RJ, Cheng S, et al. An evaluation of candidate genes of inflammation and thrombosis in relation to the risk of venous thromboembolism: the women’s genome health study. CircCardiovasc Genet. 2009; 2: 57–62.
Aksu K, Donmez A, Keser G. Inflammation-induced thrombosis: mechanisms. disease associations and management. Curr Pharm Des. 2012; 18: 1478–93.
Zahorec R. Ratio of neutrophil to lymphocyte counts–rapid and simple parameter of systemic inflammation and stress in critically ill. BratislLekListy. 2001; 102: 5–14.
Downing LJ, Strieter RM, Kadell AM, et al. Neutrophils are the initial cell type identified in deep venous thrombosis induced vein wall inflammation. Asaio J 1996; 42: 677–82.
Watts JA, Zagorski J, Gellar MA, et al. Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats. J Mol Cell Cardiol. 2006; 41: 296–307.
Heestermans M, Salloum-Asfar S, Salvatori D, et al. Role of platelets. neutrophils. and factor XII in spontaneous venous thrombosis in mice. Blood. 2016; 127(21): 2630–2637. doi:10. 1182/blood-2015-10-672766.
Pfeiler S, Stark K, Massberg S, Engelmann B. Propagation of thrombosis by neutrophils and extracellular nucleosome networks. Haematologica 2016; 102(2): 206–221. doi:10.3324/haematol.2016.142471.
Kimball AS, Obi AT, Diaz JA, Henke PK. The emerging role of NETs in venous thrombosis and immunothrombosis. Front Immunol. 2016; 7(JUN): 1–8.
Stewart GJ, Ritchie WG, Lynch PR. Venous endothelial damage produced by massive sticking and emigration of leukocytes. Am J Pathol. 1974; 74: 507–32.
Trujillo-Santos J, Di Micco P, Iannuzzo M, et al. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry. ThrombHaemost 2008; 100: 905–11.
Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657–71.
Hoffman M, Blum A, Baruch R, et al. Leukocytes and coronary heart disease. Atherosclerosis 2004; 172: 1–6.
Virchow R. Thrombose und Embolie. Gefässentzündung und septische Infektion. Gesammelte Abhandlungen zur wissenschaftlichen Medicin. Frankfurt am Main: Von Meidinger&Sohn; 1856. p. 219–732.
Huang J, Chen Y, Cai Z, Chen P. Diagnostic value of platelet indexes for pulmonary embolism. Am J Emerg Med. 2015 Jun; 33(6): 760–3.
Piech P, Obierzyński P, Staśkiewicz G, et al. The analysis of selected morphotic parameters of blood as potential diagnostics factors in pulmonary embolisms. Journal of Education. Health and Sport 2017; 7(5): 458–469.
Kurtipek E, Buyukterzi Z, Buyukterzi M, Alpaydin MS, Erdem SS. Endothelial dysfunction in patients with pulmonary thromboembolism: neutrophil to lymphocyte ratio and platelet to lymphocyte ratio. ClinRespir J. 2015.
Balta S, Demirkol S, Kucuk U. The platelet lymphocyte ratio may be useful inflammatory indicator in clinical practice. Hemodial Int. 2013; 17: 668–9.
Afzal A, Noor HA, Gill SA, et al. Leukocytosis in acute pulmonary embolism. Chest 1999; 115: 1329–32.
Sunbul M, Gerin F, Durmus E, et al. Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus nondipper hypertension. ClinExpHypertens. 2014; 36: 217–21.
Yüksel M, Yıldız A, Oylumlu M, et al. The association between platelet/lymphocyte ratio and coronary artery disease severity. AnadoluKardiyolDerg; 2014.
Buxhofer-Ausch V, Steurer M, Sormann S, et al. Influence of platelet and white blood cell counts on major thrombosis – analysis from a patient registry in essential thrombocythemia. Eur J Haematol. 2016; 97(6): 511–516.